SCHEMBL8128592

SCHEMBL8128592

CC(C)Cc1ccc(CC(=O)NC(C)(C)C)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
HPGD P15428 2/20 0.50
KDM4E B2RXH2 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MAPT P10636 1/20 0.47
CHRM1 P11229 1/20 0.46
PDE4A P27815 1/20 0.46
PTGS1 P23219 3/20 0.46
PTGS2 P35354 3/20 0.46
LMNA P02545 2/20 0.46
CYP2C9 P11712 2/20 0.46
AKR1C3 P42330 2/20 0.46
CXCR1 P25024 2/20 0.46
CXCR2 P25025 2/20 0.46
ALOX5 P09917 2/20 0.46
ALB P02768 1/20 0.46
ESR1 P03372 1/20 0.46
RARB P10826 1/20 0.46
ADRB3 P13945 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16752458 0.83 HPGD (0.47) HPGDKDM4EL3MBTL1CHRM1PDE4A
SCHEMBL8240261 0.82 HPGD (0.71) CA1CA2HPGDKDM4EL3MBTL1
SCHEMBL28522649 0.80 CXCR1 (0.50) HPGDCHRM1PDE4APTGS1PTGS2
SCHEMBL8244681 0.79 LMNA (0.48) HPGDCHRM1PDE4APTGS1PTGS2
SCHEMBL8240475 0.79 L3MBTL1 (0.73) CA1CA2HPGDKDM4EL3MBTL1
SCHEMBL10986259 0.78 MEN1 (0.59) CA1CA2HPGDMAPTLMNA
SCHEMBL24264697 0.77 HPGD (0.56) HPGDCHRM1PDE4APTGS1PTGS2
SCHEMBL3455142 0.77 CHRM1 (0.69) MAPTCHRM1PDE4APTGS1PTGS2
SCHEMBL19133623 0.75 CA1 (0.59) CA1CA2HPGDKDM4EL3MBTL1
SCHEMBL19387994 0.75 RAB9A (0.58) CA1CA2HPGDKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0519353-B1 Indolizin derivatives, process for their preparation and pharmaceutical composition containing them FUJISAWA PHARMACEUTICAL CO (JP) 2000-08-16 EP disclosed
EP-0458207-B1 Indole derivatives FUJISAWA PHARMACEUTICAL CO (JP) 1997-03-26 EP disclosed
US-5334716-A Preventing testosteron 5a-reductase mediated diseases; alopecia, acne, prostatism FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-08-02 US disclosed
US-5312829-A Testosterone 5alpha-reductase inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-05-17 US disclosed
US-5212320-A Enzyme inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-05-18 US disclosed
EP-0519353-A2 Indolizin derivatives, process for their preparation and pharmaceutical composition containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-12-23 EP disclosed
EP-0458207-A2 Indole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-11-27 EP disclosed